Metformin encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple negative breast cancer

This study is focused on metformin-encapsulating liposome functionalization with single-chain variable fragments to increase the delivery and therapeutic efficacy for Trophoblast Cell-Surface Antigen 2 overexpressing triple-negative breast cancers.